Variant report
Variant | nsv1029177 |
---|---|
Chromosome Location | chr9:16903446-16914412 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10733333 | chr9:16903446-16903447 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550962880 | chr9:16903460-16903461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10733334 | chr9:16903490-16903491 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs189823891 | chr9:16903521-16903522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369485513 | chr9:16903562-16903563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192782044 | chr9:16903572-16903573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11790433 | chr9:16903574-16903575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574754984 | chr9:16903593-16903594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548292917 | chr9:16903597-16903598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs55761409 | chr9:16903603-16903604 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs185210892 | chr9:16903611-16903612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557033856 | chr9:16903634-16903635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10756834 | chr9:16903652-16903653 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs569190747 | chr9:16903661-16903662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539211549 | chr9:16903664-16903665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370137722 | chr9:16903668-16903669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs58134658 | chr9:16903722-16903723 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs566433850 | chr9:16903732-16903733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs78488263 | chr9:16903740-16903741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564554997 | chr9:16903766-16903767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189170855 | chr9:16903771-16903772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573272345 | chr9:16903788-16903789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537460584 | chr9:16903790-16903791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573456896 | chr9:16903837-16903838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10810661 | chr9:16903850-16903851 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs578201244 | chr9:16903860-16903861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545270314 | chr9:16903900-16903901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560781364 | chr9:16903907-16903908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181832509 | chr9:16903908-16903909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7029285 | chr9:16903948-16903949 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs561389319 | chr9:16903958-16903959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531703344 | chr9:16903982-16903983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369465573 | chr9:16903988-16903989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7032158 | chr9:16904047-16904048 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs386733159 | chr9:16904080-16904081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186486418 | chr9:16904102-16904103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7032644 | chr9:16904141-16904142 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs115515145 | chr9:16904184-16904185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548630559 | chr9:16904190-16904191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150999884 | chr9:16904193-16904194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374225029 | chr9:16904196-16904197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7032420 | chr9:16904202-16904203 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs188121210 | chr9:16904203-16904204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77037377 | chr9:16904244-16904245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554052160 | chr9:16904248-16904249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115418627 | chr9:16904275-16904276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543259402 | chr9:16904279-16904280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7032909 | chr9:16904303-16904304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs180889050 | chr9:16904324-16904325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543829124 | chr9:16904331-16904332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:16902000-16914800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr9:16908200-16908600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr9:16911800-16912800 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr9:16911800-16912800 | Enhancers | A549 | lung |
5 | chr9:16912200-16912800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr9:16912200-16912800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr9:16912200-16912800 | Enhancers | Osteobl | bone |
8 | chr9:16912800-16914800 | Weak transcription | Osteobl | bone |
9 | chr9:16912800-16915200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr9:16912800-16921800 | Weak transcription | Muscle Satellite Cultured Cells | -- |
11 | chr9:16912800-16928000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |